Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine

doi:10.4252/wjsc.v12.i8.814

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11158)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

719

WORD

148

HTML

7522

Figures (1-4)

668

Tables (1-3)

284

Sum=9341

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

593

Download

1224

Sum=1817

Aug 26, 2020 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (52)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Aug 26, 2020; 12(8): 814-840
Published online Aug 26, 2020. doi: 10.4252/wjsc.v12.i8.814

Full Size Figure Download Figure

Figure 1 Schematic diagram of mesenchymal stem cells-based regenerative medicine. Mesenchymal stem cells can be easily isolated from a variety of tissues, and the multiple differentiation and immunomodulatory properties of mesenchymal stem cells make them ideal candidates for cell therapy. ESCs: Embryonic stem cells; iPSCs: Induced pluripotent stem cells; CD: Cluster of differentiation; MSCs: Mesenchymal stem cells; DC: Dendritic cells; NK cells: Natural killer cells; M1: Microglia M1 phenotype; M2: Microglia M2 phenotype; Treg: Regulatory cell.

Citation: Ma ZJ, Yang JJ, Lu YB, Liu ZY, Wang XX. Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine. World J Stem Cells 2020; 12(8): 814-840
URL: https://www.wjgnet.com/1948-0210/full/v12/i8/814.htm
DOI: https://dx.doi.org/10.4252/wjsc.v12.i8.814